Furthermore, taurolithocholate 3-sulfate, a bile acid metabolite, negatively correlates with liver fibrosis by exerting anti-inflammatory and anti-fibrotic effects through FXR and TGR5 pathways [23, 24]. Here, GPBAR1 is linked to Hepatic fibrosis.